131 related articles for article (PubMed ID: 11736725)
1. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Sharma VK; Sahai AV; Corder FA; Howden CW
Aliment Pharmacol Ther; 2001 Dec; 15(12):1939-47. PubMed ID: 11736725
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
4. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
[TBL] [Abstract][Full Text] [Related]
6. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003
[TBL] [Abstract][Full Text] [Related]
7. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
[TBL] [Abstract][Full Text] [Related]
8. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Taskin V; Gurer I; Ozyilkan E; Sare M; Hilmioglu F
Helicobacter; 2000 Mar; 5(1):38-40. PubMed ID: 10672050
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
Archimandritis A; Balatsos V; Delis V; Mentis A; Kastanas K; Scandalis N
J Clin Gastroenterol; 1995 Jan; 20(1):12-6. PubMed ID: 7884169
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Jönsson B
Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
[TBL] [Abstract][Full Text] [Related]
12. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
Carpintero P; Blanco M; Pajares JM
Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
[TBL] [Abstract][Full Text] [Related]
19. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Sung JJ; Leung WK; Suen R; Leung VK; Chan FK; Ling TK; Lau JY; Lee YT; Ng EK; Cheng AF; Chung SC
Dig Dis Sci; 1997 Dec; 42(12):2524-8. PubMed ID: 9440631
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
